Is ctBP2 overexpression associated with tumorigenesis and poor clinical outcome of prostate cancer?
CtBP2 is overexpressed in prostate cancer, and its increased expression is closely associated with tumor progression and the outcome of prostate cancer.
The results suggest that PO depends on the nature of the pedalling activity. Moreover, PO under CE TT4 is a relevant predictor of MAP. It seems to be important to measure the MAP by taking into account the cycling conditions, considering that coaches and scientists use this parameter to assess the aerobic potential of athletes and determine the exercise intensities useful for monitoring adaptation to training.